It has been confirmed that Glaxo has contacted a dermatological research center in Marburg, Germany regarding the completion of the final phase of trials for Dutasteride on hair loss. Kevin J. McElwee of Keratin.com has verified that his superiors were contacted directly by Glaxo regarding plans to make use of their facilities for this purpose.
Glaxo plans to submit an NDA (New Drug Application) in the beginning of 2001 for Dutasteride’s use in treating BPH (Benign Prostate Hyperplasia), however Glaxo has a reputation for making promises and breaking dates, so let’s keep our fingers crossed but expectations in cheque.
Nevertheless, it is good news to note that they found reason to continue trials on hair loss, and there have been rumors of its amazing effectiveness at treating hair loss.
For those of you who are not familiar with Dutasteride, to put it in layman’s terms, it is a treatment which works similarly to Finasteride, only it inhibits both types of 5-alpha reductase, rather than just one type. The potential benefits of it are needless to say high, however the safety profile seems to be a potential problem, as the greater amount of DHT inhibition tends to equal a greater risk of side effects.